These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 30254487)
1. Overexpression of kinesin family member 20A is associated with unfavorable clinical outcome and tumor progression in epithelial ovarian cancer. Li H; Zhang W; Sun X; Chen J; Li Y; Niu C; Xu B; Zhang Y Cancer Manag Res; 2018; 10():3433-3450. PubMed ID: 30254487 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of Kinesin Family Member 20A Correlates with Disease Progression and Poor Prognosis in Human Nasopharyngeal Cancer: A Retrospective Analysis of 105 Patients. Liu SL; Lin HX; Qiu F; Zhang WJ; Niu CH; Wen W; Sun XQ; Ye LP; Wu XQ; Lin CY; Song LB; Guo L PLoS One; 2017; 12(1):e0169280. PubMed ID: 28081138 [TBL] [Abstract][Full Text] [Related]
3. High Expression of KIF20A Is Associated with Poor Overall Survival and Tumor Progression in Early-Stage Cervical Squamous Cell Carcinoma. Zhang W; He W; Shi Y; Gu H; Li M; Liu Z; Feng Y; Zheng N; Xie C; Zhang Y PLoS One; 2016; 11(12):e0167449. PubMed ID: 27941992 [TBL] [Abstract][Full Text] [Related]
4. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma. Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of GPNMB predicts an unfavorable outcome of epithelial ovarian cancer. Ma RQ; Tang ZJ; Ye X; Cheng HY; Sun KK; Chang XH; Cui H Arch Gynecol Obstet; 2018 May; 297(5):1235-1244. PubMed ID: 29428978 [TBL] [Abstract][Full Text] [Related]
6. Formyl peptide receptor 2 expression predicts poor prognosis and promotes invasion and metastasis in epithelial ovarian cancer. Xie X; Yang M; Ding Y; Yu L; Chen J Oncol Rep; 2017 Dec; 38(6):3297-3308. PubMed ID: 29039544 [TBL] [Abstract][Full Text] [Related]
7. Aberrant KIF20A Expression Is Associated with Adverse Clinical Outcome and Promotes Tumor Progression in Prostate Cancer. Zhang Z; Chai C; Shen T; Li X; Ji J; Li C; Shang Z; Niu Y Dis Markers; 2019; 2019():4782730. PubMed ID: 31565099 [TBL] [Abstract][Full Text] [Related]
8. Stonin 2 Overexpression is Correlated with Unfavorable Prognosis and Tumor Invasion in Epithelial Ovarian Cancer. Sun X; Zhang W; Li H; Niu C; Ou Y; Song L; Zhang Y Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28758939 [TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of KIF2A and HER2-Neu Overexpression in Patients With Epithelial Ovarian Cancer. Wang D; Zhu H; Ye Q; Wang C; Xu Y Medicine (Baltimore); 2016 Feb; 95(8):e2803. PubMed ID: 26937910 [TBL] [Abstract][Full Text] [Related]
10. Tumor Forkhead Box Q1 Is Elevated, Correlates with Increased Tumor Size, International Federation of Gynecology and Obstetrics Stage but Worse Overall Survival in Epithelial Ovarian Cancer Patients. Wang X; Zhu X Cancer Biother Radiopharm; 2022 Nov; 37(9):837-842. PubMed ID: 33761267 [No Abstract] [Full Text] [Related]
11. Long noncoding RNA LINC00673 promotes the proliferation and metastasis of epithelial ovarian cancer by associating with opioid growth factor receptor. Zheng T; Qiu J; Li C; Lin X; Tang X; Hua K Onco Targets Ther; 2019; 12():6145-6156. PubMed ID: 31496722 [TBL] [Abstract][Full Text] [Related]
12. NEDD9 overexpression is associated with the progression of and an unfavorable prognosis in epithelial ovarian cancer. Wang H; Mu X; Zhou S; Zhang J; Dai J; Tang L; Xiao L; Duan Z; Jia L; Chen S Hum Pathol; 2014 Feb; 45(2):401-8. PubMed ID: 24439227 [TBL] [Abstract][Full Text] [Related]
13. Elevated growth differentiation factor 15 expression predicts poor prognosis in epithelial ovarian cancer patients. Zhang Y; Hua W; Niu LC; Li SM; Wang YM; Shang L; Zhang C; Li WN; Wang R; Chen BL; Xin XY; Zhang YQ; Wang J Tumour Biol; 2016 Jul; 37(7):9423-31. PubMed ID: 26781874 [TBL] [Abstract][Full Text] [Related]
14. MYH9 overexpression correlates with clinicopathological parameters and poor prognosis of epithelial ovarian cancer. Liu L; Yi J; Deng X; Yuan J; Zhou B; Lin Z; Zeng Z Oncol Lett; 2019 Aug; 18(2):1049-1056. PubMed ID: 31423165 [TBL] [Abstract][Full Text] [Related]
15. Elevated expression of MAC30 predicts lymph node metastasis and unfavorable prognosis in patients with epithelial ovarian cancer. Yang S; Li H; Liu Y; Ning X; Meng F; Xiao M; Wang D; Lou G; Zhang Y Med Oncol; 2013 Mar; 30(1):324. PubMed ID: 23254963 [TBL] [Abstract][Full Text] [Related]
16. KCNMA1-AS1 attenuates apoptosis of epithelial ovarian cancer cells and serves as a risk factor for poor prognosis of epithelial ovarian cancer. Ma SY; Wei P; Qu F Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4629-4641. PubMed ID: 31210304 [TBL] [Abstract][Full Text] [Related]
17. KIF20A expression as a prognostic indicator and its possible involvement in the proliferation of ovarian clear‑cell carcinoma cells. Kawai Y; Shibata K; Sakata J; Suzuki S; Utsumi F; Niimi K; Sekiya R; Senga T; Kikkawa F; Kajiyama H Oncol Rep; 2018 Jul; 40(1):195-205. PubMed ID: 29749467 [TBL] [Abstract][Full Text] [Related]
18. Expression of Placenta Growth Factor Is Associated with Unfavorable Prognosis of Advanced-Stage Serous Ovarian Cancer. Meng Q; Duan P; Li L; Miao Y Tohoku J Exp Med; 2018 Apr; 244(4):291-296. PubMed ID: 29643276 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-130b functions as a tumor suppressor by regulating RUNX3 in epithelial ovarian cancer. Paudel D; Zhou W; Ouyang Y; Dong S; Huang Q; Giri R; Wang J; Tong X Gene; 2016 Jul; 586(1):48-55. PubMed ID: 27048832 [TBL] [Abstract][Full Text] [Related]
20. Positive expression of KIF20A indicates poor prognosis of glioma patients. Duan J; Huang W; Shi H Onco Targets Ther; 2016; 9():6741-6749. PubMed ID: 27843327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]